Matthew Heckroth1, Robert T Luckett2, Chris Moser1, Dipendra Parajuli2,3, Thomas L Abell2. 1. Department of Medicine, University of Louisville. 2. Department of Medicine, Division of Gastroenterology, Hepatology & Nutrition, University of Louisville. 3. Robley Rex Va Medical Center, Louisville, KY.
Abstract
GOAL: A comprehensive review of treatments for nausea and vomiting (N/V). BACKGROUND: N/V are common symptoms encountered in medicine. While most cases of acute N/V related to a specific cause can be straightforward to manage, other cases of acute N/V such as chemotherapy-induced N/V and especially chronic unexplained N/V can be difficult to control, leading to a significant decline in the patient's quality of life and increased cost of medical care from repeated hospitalizations. STUDY: Traditional management has relied on pharmacotherapy which may be inadequate in a certain proportion of these patients. Many of the medications used in the management of N/V have significant side effect profiles making the need for new and improved interventions of great importance. RESULTS: This review covers a broad review of the pathophysiology of N/V, pharmacotherapy, including safety concerns and controversies with established pharmaceuticals, newer immunotherapies, bioelectrical neuromodulation (including gastric electrical stimulation), behavioral and surgical therapies, and complementary medicine. CONCLUSION: On the basis of emerging understandings of the pathophysiology of N/V, improved therapies are becoming available.
GOAL: A comprehensive review of treatments for nausea and vomiting (N/V). BACKGROUND: N/V are common symptoms encountered in medicine. While most cases of acute N/V related to a specific cause can be straightforward to manage, other cases of acute N/V such as chemotherapy-induced N/V and especially chronic unexplained N/V can be difficult to control, leading to a significant decline in the patient's quality of life and increased cost of medical care from repeated hospitalizations. STUDY: Traditional management has relied on pharmacotherapy which may be inadequate in a certain proportion of these patients. Many of the medications used in the management of N/V have significant side effect profiles making the need for new and improved interventions of great importance. RESULTS: This review covers a broad review of the pathophysiology of N/V, pharmacotherapy, including safety concerns and controversies with established pharmaceuticals, newer immunotherapies, bioelectrical neuromodulation (including gastric electrical stimulation), behavioral and surgical therapies, and complementary medicine. CONCLUSION: On the basis of emerging understandings of the pathophysiology of N/V, improved therapies are becoming available.
Authors: F Roila; A Molassiotis; J Herrstedt; M Aapro; R J Gralla; E Bruera; R A Clark-Snow; L L Dupuis; L H Einhorn; P Feyer; P J Hesketh; K Jordan; I Olver; B L Rapoport; J Roscoe; C H Ruhlmann; D Walsh; D Warr; M van der Wetering Journal: Ann Oncol Date: 2016-09 Impact factor: 32.976
Authors: Brian R Davis; Irene Sarosiek; Mohammad Bashashati; Ben Alvarado; Richard W McCallum Journal: J Gastrointest Surg Date: 2016-11-28 Impact factor: 3.452
Authors: R A Hejazi; T H Lavenbarg; M Pasnoor; M Dimachkie; P Foran; L Herbelin; R W McCallum Journal: Neurogastroenterol Motil Date: 2011-02-16 Impact factor: 3.598
Authors: Frank K Friedenberg; Amiya Palit; Henry P Parkman; Alexandra Hanlon; Deborah B Nelson Journal: Am J Gastroenterol Date: 2007-12-05 Impact factor: 10.864
Authors: Sundus Bhatti; Imad Jaafar; Hamza Hassan; Hadi Atassi; Abigail Stocker; Michael Hughes; Christina Pinkston; Gerald Dryden; Thomas Abell Journal: Neuromodulation Date: 2020-02-18